| CEO Name | Paul Hudson |
| Nationality | United Kingdom |
| Net Worth Estimation | $40 million |
Paul Hudson's estimated net worth of around $40 million is primarily derived from his compensation as CEO of Sanofi S.A., including salary, bonuses, stock options, and past executive roles at Novartis and AstraZeneca. His wealth also reflects accrued equity awards and performance-based long-term incentives tied to Sanofi's financial performance.
Paul Hudson, CEO of Sanofi S.A., has an estimated net worth of $40,000,000, which is 40% of the maximum CEO net worth and 400% of the minimum CEO net worth in the healthcare business category. His net worth places him in the mid-range compared to peers in the industry.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Paul Hudson Performance in Sanofi S.A.
Paul Hudson, CEO of Sanofi S.A., demonstrates strategic leadership with a focus on innovation and global expansion in pharmaceuticals. His decision-making emphasizes R&D investment, portfolio diversification, and digital transformation to enhance productivity. Under Hudson's leadership, Sanofi has improved financial performance, strengthened its pipeline, and expanded market presence, significantly boosting shareholder value.
Latest News
Sanofi S.A. and CEO Paul Hudson's Strategic Growth and Innovation in 2025
Sanofi under CEO Paul Hudson reported strong Q2 and Q3 2025 financial results driven by key product launches and acquisitions, including Blueprint Medicines to expand its rare immunology portfolio. Hudson emphasizes a patient-focused strategy, significant capital redeployment, and a $625 million commitment to biotech innovation through Sanofi Ventures to maintain growth and advance its vaccine and immunology pipelines.
Source: http://www.sanofi.com/en/media-room/press-releases/2025/2025-06-02-05-00-00-3091541